KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Assets: 2009-2024

Historic Non-Current Assets for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to $431.5 million.

  • Novavax's Non-Current Assets fell 66.28% to $205.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.3 million, marking a year-over-year decrease of 66.28%. This contributed to the annual value of $431.5 million for FY2024, which is 33.98% down from last year.
  • As of FY2024, Novavax's Non-Current Assets stood at $431.5 million, which was down 33.98% from $653.6 million recorded in FY2023.
  • In the past 5 years, Novavax's Non-Current Assets registered a high of $653.6 million during FY2023, and its lowest value of $334.3 million during FY2020.
  • Moreover, its 3-year median value for Non-Current Assets was $555.3 million (2022), whereas its average is $546.8 million.
  • In the last 5 years, Novavax's Non-Current Assets spiked by 341.52% in 2020 and then slumped by 33.98% in 2024.
  • Over the past 5 years, Novavax's Non-Current Assets (Yearly) stood at $334.3 million in 2020, then climbed by 26.13% to $421.6 million in 2021, then skyrocketed by 31.70% to $555.3 million in 2022, then increased by 17.71% to $653.6 million in 2023, then plummeted by 33.98% to $431.5 million in 2024.